Table 3

CPG characteristics

	1 AUS RWH	2 AUS KEMH	3 NZ ADHB	4 NZ HVDHB	5 CA CDA	6 UK NUH	7 UK BHT
How described by the authors	A guideline	Clinical practice guideline	Guideline	Care policy	Clinical practice guideline	Guideline	Guideline
Evidence and/or expert consensus based	Evidence	Evidence	Evidence	Evidence	Evidence and consensus	Evidence	Evidence
Clinical indication	Women with GDM	Diabetes in pregnancy	Women with diabetes in pregnancy	Pre-existing and gestational diabetes	Pre-existing and gestational diabetes	Pregnant women with diabetes (incl GDM)	Pregnant women with diabetes and GDM
Target users	Health professionals only (not further defined)	Not defined	All clinicians in maternity, all access holders	All midwives, obstetricians, all access holders, dieticians, endocrinologists, diabetes nurses, dietician	Not stated	All midwives, diabetic nurses. All medical staff	All Trust staff working in whatever capacity
Stakeholders involved	Not disclosed	Not disclosed	Diabetes team (not further defined)	Not disclosed	Broad clinical team (individual clinicians)	Broad clinical team (specialties only)	Broad clinical team (individual clinicians)
Interventions included	Education, self-monitoring, diet changes, prescription medication, referral to high-risk team if certain criteria are met, two weekly visits, elective delivery from 38 weeks if medicated	Education, self-monitoring, diet changes, prescription medication, referral to high-risk team if certain criteria are met, two weekly visits, elective delivery from 38 weeks if medicated, elective cesarean for macrosomia	Education, self-monitoring, diet changes, prescription medication, referral to high-risk team if certain criteria are met, 2–3 weekly visits, elective delivery from 38 weeks if medicated or uncontrolled, delivery by 41 weeks in GDM	Education, self-monitoring, prescription medication, diet changes, referral to high-risk team if certain criteria are met, 2–4 weekly visits, delivery by 41 weeks unless clinical indications for earlier delivery	Education, self-monitoring, diet changes, prescription medication	Education, self-monitoring, prescription medication, diet changes, elective delivery from 37 weeks if pre-existing, 38 weeks if uncontrolled GDM or GDM on medication, no later than 40+6 if GDM	Education, self-monitoring, diet changes, prescription medication, referral to high-risk team if certain criteria are met, community pathway established, at least two weekly visits, elective delivery from 37 weeks if pre-existing, 39 weeks if GDM and medicated. Deliver by 40+6 if GDM
Includes in-labour management	Yes	Comprehensive	Yes	No	Yes	No	Comprehensive
Includes antenatal steroid management	Yes	Yes	Comprehensive	Yes	No	No	Comprehensive
Relied on/Referenced NICE	No	Referenced	No	Referenced	Referenced	Relied on	Relied on

ADHB, Auckland DHB; BHT, Barts Health Trust; CDA, Canadian Diabetic Association; CPG, clinical practice guideline ; GDM, gestational diabetes mellitus; HVDHB, Hutt Valley DHB; KEMH, King Edward Memorial Hospital; NICE, The National Institute for Health and Care Excellence; NUH, Nottingham University Hospital; RWH, Royal Women’s Hospital.